Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DDAVP Response in Hemophilia A Carriers
NCT02506023Phase 1Completed
- Sponsor
- Emory University
- Start
- Jul 2015
- Primary completion
- Jun 2018
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of desmopressin in hemophilia A (3 arms), sponsored by Emory University. Primary endpoint: Percentage of subjects that achieve and sustain >50% increase in Factor VIII antigen levels at 240 minutes. Started Jul 2015; status: completed.
02
Drugs
desmopressin
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT02506023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02506023.